Cannabis Industry Investor Presentations Now Available for On-Demand Viewing

$CLVR
$GNRS
$IMCC
$INCR
Biotechnology: Pharmaceutical Preparations
Health Care
Business Services
Finance
Get the next $CLVR alert in real time by email

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations

NEW YORK, Sept. 13, 2021 /CNW/ - Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the September 8th & 9th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com.

REGISTER OR LOGIN NOW AT:  https://bit.ly/3BUC6w8

All presentations will be available for 24/7 on-demand replay for 90 days. Investors, advisors and analysts may also download shareholder materials from the "virtual trade booth" for the next three weeks.

Presentations:

Presenting Company

Ticker(s)

Innocan Pharma Corp.

((INNPF, CSE:INNO)

MariMed Inc.

OTCQX: MRMD

The Valens Company Inc.

((VLNCF, TSX:VLNS)

Nova Cannabis Inc.

((NVACF, TSX:NOVC)

InMed Pharmaceuticals Inc.

Nasdaq: INM

Vibe Growth Corp.

((VIBEF, CSE:VIBE)

1933 Industries Inc.

OTCQB: TGIFF | CSE: TGIF

MediPharm Labs Corp.

((MEDIF, TSX:LABS)

IM Cannabis Corp.

((IMCC, CSE:IMCC)

NewLake Capital Partners, Inc.

OTCQX: NLCP

Aleafia Health Inc.

((ALEAF, TSX:AH)

InterCure Ltd.

((INCR, TSX:INCR)

Verano Holdings Corp.

((VRNOF, CSE:VRNO)

Fire & Flower Holdings Corp.

((FFLWF, TSX:FAF)

Delta 9 Cannabis Inc,

((DLTNF, TSX:DN)

Clever Leaves Holdings Inc.

(NASDAQ: CLVR, CLVRW)

Australis Capital Inc.

((AUSAF, CSE:AUSA)

Lowell Farms Inc.

((LOWLF, CSE:LOWL)

Flower One Holdings Inc.

((FLOOF, CSE:FONE)

Sugarbud Craft Growers Corp.

((SBUDF, TSXV:SUGR)

Greenrose Acquisition Corp.

((GNRS, GNRSU, GNRSW))

To facilitate investor relations scheduling, for more information about the program and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor ConferencesSM

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.



A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group's suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

SOURCE VirtualInvestorConferences.com

Cision View original content: http://www.newswire.ca/en/releases/archive/September2021/13/c3553.html

Get the next $CLVR alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CLVR
$GNRS
$IMCC
$INCR

CompanyDatePrice TargetRatingAnalyst
5/18/2022$13.00Speculative Buy → Buy
Canaccord Genuity
12/23/2021$12.00 → $10.00Buy
Canaccord Genuity
11/29/2021$6.00Buy
HC Wainwright & Co.
11/12/2021$13.00 → $12.00Buy
Canaccord Genuity
10/5/2021$8.00Buy
ROTH Capital
7/27/2021$13.00Buy
Canaccord Genuity
7/23/2021Market Perform
Cowen
7/14/2021Buy
Desjardins
More analyst ratings

$CLVR
$GNRS
$IMCC
$INCR
Press Releases

Fastest customizable press release news feed in the world

See more
  • IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

    Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023. The Company's audited consolidated financial statements for the fiscal years ended December 31, 2024 and 2023 and accompanying manage

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
  • IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

    TORONTO and GLIL YAM, Israel, March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens. The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
  • InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

    NEW YORK and HERZLIYA, Israel, Feb. 12, 2025 /PRNewswire/ -- InterCure Ltd. (NASDAQ:INCR) (TASE: INCR) (dba Canndoc) ("InterCure" or the "Company"), announces today that Mr. Ehud Barak will step down as Chairman of the board of directors of the Company (the "Board"), effective February 13, 2025. He will be succeeded by Mr. Alexander Rabinovich, who has successfully led the Company as CEO for the past five years, executing hundreds of percentages of profitable growth, building strategic international partnerships, and establishing InterCure's position as a leader in pharmaceutical cannabis. Mr. Barak, who is marking his 83rd birthday today, has decided to pursue personal endeavors after six

    $INCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

$CLVR
$GNRS
$IMCC
$INCR
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CLVR
$GNRS
$IMCC
$INCR
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$CLVR
$GNRS
$IMCC
$INCR
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CLVR
$GNRS
$IMCC
$INCR
Leadership Updates

Live Leadership Updates

See more
  • IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

    TORONTO and GLIL YAM, Israel, Sept. 11, 2024 /PRNewswire/ --  IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC) (CSE:IMCC), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Mr. Shmulik Arbel has been appointed to the Company's board of directors (the "Board") effective September 9, 2024. Mr. Arbel brings a wealth of experience in strategic plans that drive profitability, as well as, finance and corporate governance, further strengthening the company's commitment to driving growth while focusing on sustainable profitability. "We are thrilled to welcome Shmulik to our Board of Directors," said Oren Shuster, Chief Executive Officer of

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
  • IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

    TORONTO and GLIL YAM, Israel, Oct. 10, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Uri Birenberg will join the company's leadership team as Chief Financial Officer effective October 10, 2023.  This appointment strengthens IMC's financial leadership and strategic direction for achieving sustainable profitability. "We're delighted to welcome Uri as our new Chief Financial Officer at IMC. His impressive track record and extensive experience with large scale international organizations, as well as with startups, make him an outstandin

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
  • Clever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023

    TOCANCIPÁ, Colombia, May 26, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW))) ("Clever Leaves" or the "Company"), a global medicinal cannabis company, reminds shareholders that it will hold its 2023 Annual Meeting of Shareholders (the "Annual Meeting") on Friday, June 2, 2023 at 10:00 a.m. Eastern Time. The Annual Meeting will be in a virtual-only format. Clever Leaves reminds investors that its board has recommended that shareholders vote "FOR" the proposal to elect each of the five (5) nominees named in the proxy statement to the Board of Directors, "FOR" the appointment of Marcum LLP as the Company's independent registered public accounting firm to serve as in

    $CLVR
    Biotechnology: Pharmaceutical Preparations
    Health Care

$CLVR
$GNRS
$IMCC
$INCR
Financials

Live finance-specific insights

See more
  • IM Cannabis Reports Fourth Quarter and Full Year 2024 Financial Results

    Q4 2024 Caps a Year of Strategic and Operational Improvements for IMC with 25% Revenue Growth, 42% decrease in Operating Expenses, and $0.5M Adjusted EBITDA Profit TORONTO and GLIL YAM, Israel, March 31, 2025 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, is pleased to announce its financial results for the fourth quarter and year ended December 31, 2024. Unless otherwise stated, all amounts are reported in Canadian dollars and are compared to the quarter ended December 31, 2023. The Company's audited consolidated financial statements for the fiscal years ended December 31, 2024 and 2023 and accompanying manage

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
  • IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

    TORONTO and GLIL YAM, Israel, March 20, 2025 /PRNewswire/ -- IM Cannabis Corp. (CSE:IMCC) (NASDAQ:IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2024 ended December 31, 2024, on Monday, March 31, 2025 before the market opens. The Company will host a zoom web conference on the same day at 9:00a.m. ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here. All relevant information will be sent upon registration. If you are unable to join us live, a

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care
  • IM Cannabis Reports Third Quarter Financial Results

    IMC pairs a +12% increase in revenue with a -16% decrease in the total operating expenses, building a solid foundation to deliver in 2025. TORONTO and GLIL YAM, Israel, Nov. 14, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ:IMCC) (CSE:IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2024. All amounts are reported in Canadian dollars and compared to the quarter ended September 30, 2023, unless otherwise stated. Q3 2024 Financial Highlights +12% increase in Revenue to $13.9M vs. $12.4M in Q3, 2023. Adjusting for the revocation of the Oranim deal, increases the revenue to +51% or $4.7M vs

    $IMCC
    Medicinal Chemicals and Botanical Products
    Health Care

$CLVR
$GNRS
$IMCC
$INCR
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more